ArticleTranslational lung cancer research2024
Overcoming acquired resistance following osimertinib administration in EGFR-mutant lung adenocarcinoma.
Kyoichi Kaira et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it